Athersys
ATHX
#10565
Rank
$0.83 M
Marketcap
$0.01350
Share price
-33.50%
Change (1 day)
-98.90%
Change (1 year)

Athersys (ATHX) - Cash on Hand

Cash on Hand as of September 2023 : $1.02 Million USD

According to Athersys's latest financial reports the company has $1.02 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Athersys - Cash on Hand chart (from 2006 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31$9.03 M-75.84%
2021-12-31$37.4 M-27.43%
2020-12-31$51.54 M47.1%
2019-12-31$35.04 M-31.37%
2018-12-31$51.05 M74.17%
2017-12-31$29.31 M98.71%
2016-12-31$14.75 M-35.93%
2015-12-31$23.02 M-11.87%
2014-12-31$26.12 M-18.22%
2013-12-31$31.94 M25.12%
2012-12-31$25.53 M99.73%
2011-12-31$12.78 M-15.79%
2010-12-31$15.18 M-28.73%
2009-12-31$21.3 M-23.95%
2008-12-31$28.01 M-21.59%
2007-12-31$35.72 M
2003-12-31$18.9 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
$9.44 B 925,880.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$14.98 B 1,468,919.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$16.50 B 1,617,743.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
$4.50 B 441,468.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$18.56 B 1,819,703.92%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
$0.34 B 34,166.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$18.21 B 1,785,586.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$10.45 B 1,024,596.08%๐Ÿ‡ซ๐Ÿ‡ท France